| CASE REPORT |
|
| Year : 2012 | Volume
: 9
| Issue : 3 | Page : 93-95 |
|
|
Polyglandular autoimmune syndrome: We should entertain this possibility more than often
Jyoti Jain1, Shashank Banait2, Ulhas N Jajoo1, Harshal Pawade1
1 Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sevagram, India
2 Department of Ophthalmology, Netra Hospital, Ingole Chowk, Wardha, Maharashtra, India
Correspondence Address:
Jyoti Jain
Department of Medicine, Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha - 442 102, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-0354.99653
|
|
|
Polyglandular autoimmune syndrome (PGS) type III is a rare immune-mediated disorder. Common clinical presentation includes symptoms of hypothyroidism, diabetes, pernicious anemia, vitiligo, and autoimmune alopecia. Other autoimmune disorders associated with PGA syndrome III are celiac disease, hypogonadism, myasthenia gravis, sarcoidosis, rheumatoid arthritis, inflammatory bowel disease, gastric carcinoid tumor, and hepatitis C. We report a case of PGA syndrome type III in an 18-year-old male. Hashimoto's thyroiditis was diagnosed when he was 13 years old. Clinical examination and laboratory findings revealed a PGS due to the presence of immune-mediated diabetes mellitus (DM) (type 1 DM), insufficient insulin hormone response, and thyroid autoimmunity. The patient had neither adrenal disease nor hyperparathyroidism. Therefore, we concluded that this patient has PGS type III A. When a patient presented with PGS, we should continue to consider other glandular hypofunction when evaluating patients with any type of endocrine hypofunction, as the risk of multiple glandular involvements is quite significant. Various therapeutic interventions if started early after diagnosis reduces the possible complications of the illness. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
